Icu Medical Inc/de Form 4 insider transactions

Christian Voigtlander, COO of ICU Medical, exercised stock options and sold shares of common stock on May 16 and May 19, 2025.

Christian Voigtlander, COO of ICU Medical, exercised stock options and sold shares of common stock on May 14 and 15, 2025.

ICU Medical's Chief Information Officer, Ben Sousa, sold 2,000 shares of common stock at an average price of $137.3571 on May 15, 2025.

Director Elisha W. Finney reports acquisition and disposal of ICU Medical Inc. stock and derivative securities.

Director Kolleen Kennedy of ICU Medical Inc. reports acquisition and disposal of common stock and derivative securities.

Director David F. Hoffmeister reports transactions involving ICU Medical Inc. stock, including the acquisition and disposal of restricted stock units.

Director Donald Abbey reports acquisition and disposal of ICU Medical Inc. stock and derivative securities on May 13, 2025.

Director Laurie Hernandez reports the acquisition and disposal of ICU Medical Inc. stock units.

Director David C. Greenberg reports the acquisition and disposal of ICU Medical Inc. stock and derivative securities.

Brian Bonnell, CFO of ICU Medical, reports the vesting of 3,248 common stock units on March 15, 2025, according to a Form 4 filing.

Vivek Jain, Chairman and CEO of ICU Medical Inc., reports the acquisition and disposal of common stock and restricted stock units on March 15, 2025.

Virginia Sanzone, VP and General Counsel of ICU Medical Inc., reports the vesting and subsequent disposal of restricted stock units to cover tax obligations.

Ben Sousa, Chief Information Officer of ICU Medical Inc., reports the acquisition and disposal of common stock and restricted stock units on March 15, 2025.

Christian Voigtlander, COO of ICU Medical, reports the vesting and subsequent disposal of restricted stock units to cover tax obligations.

Daniel Woolson, VP, GM-Infusion Capital at ICU Medical, reports the vesting and subsequent disposal of performance-based restricted stock units (PRSUs) and common stock.

ICU Medical's Chairman and CEO, Vivek Jain, reports the acquisition of 15,848 restricted stock units in a recent Form 4 filing.

Virginia Sanzone, VP and General Counsel of ICU Medical Inc., reports the vesting and disposal of restricted stock units.

ICU Medical Inc.'s Chairman and CEO, Vivek Jain, reports the disposition and acquisition of common stock and derivative securities, including restricted stock units, in a recent Form 4 filing.

Ben Sousa, Chief Information Officer of ICU Medical Inc., reports the acquisition and disposal of common stock and restricted stock units on March 7th and 8th, 2025.

Daniel Woolson, VP, GM-Infusion Capital at ICU Medical, reports the vesting and disposal of restricted stock units.

Christian Voigtlander, Chief Operating Officer of ICU Medical Inc., reports the acquisition and disposal of common stock and restricted stock units on March 7, 2025.

Brian Michael Bonnell, CFO of ICU Medical, reports the vesting and disposal of restricted stock units.

ICU Medical's CEO, Vivek Jain, executed a pre-planned transaction involving the exercise of stock options and subsequent sale of shares on January 2, 2025.

Daniel Woolson, VP and GM of Infusion Capital at ICU Medical Inc., sold 2,241 shares of common stock on December 6, 2024.

ICU Medical's Chairman and CEO, Vivek Jain, exercised stock options and sold shares on December 2, 2024, under a pre-arranged 10b5-1 trading plan.

ICU Medical director David C. Greenberg exercised stock options and sold shares on November 27, 2024.

Christian B. Voigtlander, Chief Operating Officer of ICU Medical Inc., exercised stock options and sold the resulting shares on November 27, 2024.

ICU Medical's Chief Operating Officer, Christian B. Voigtlander, exercised stock options and sold shares in multiple transactions on November 25th and 26th, 2024.

ICU Medical's Chairman and CEO, Vivek Jain, exercised stock options and sold shares of common stock on November 1, 2024, under a pre-arranged Rule 10b5-1 trading plan.

ICU Medical's Chairman and CEO, Vivek Jain, exercised stock options and sold shares of common stock on October 1, 2024, under a pre-arranged Rule 10b5-1 trading plan.